Youll receive a tracking number when your order ships
Separately, RegeneRx's ophthalmic formulation RGN-259 completed Phase 3 trials (ARISE-1 and ARISE-2) for dry eye with mixed results
Related research: For distinct compound, component, or formulation evidence and safety context, read BPC-157 Peptide: Benefits, Uses, Side Effects, Dosage, and Research and TB-500 Peptide: Benefits, Uses, Side Effects, Dosage, and Research
Information for Patients Inform patients that use of local anesthetics may cause methemoglobinemia, a serious condition that must be treated promptly
In the spleen, BPC 157-treated rats have less apparent sinusoidal congestion, and dilatation and enlargement of red pulp leading to reduction of white pulp